Press Releases
Filters
December 15, 2023
Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora "Doretta" Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D Officer
December 15, 2023
Viatris Shareholders Re-elect All Nominated Directors and Approve All Voting Matters at Annual Meeting of Shareholders
November 13, 2023
Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
November 7, 2023
Viatris Reports Strong Financial and Operational Results for the Third Quarter 2023 and Reaffirms Full-Year 2023 Adjusted EBITDA and Free Cash Flow Guidance Ranges[1]
October 30, 2023
Viatris to Host Webinar: The Power of Partnership to Address Antimicrobial Resistance
October 23, 2023
Viatris Named to Forbes' Annual List of the World's Best Employers for the Third Year in a Row
Displaying 41 - 50 of 137